39.74
price down icon3.40%   -1.40
after-market アフターアワーズ: 39.74
loading

Structure Therapeutics Inc Adr (GPCR) 最新ニュース

pulisher
Nov 03, 2024

abrdn plc Has $9.53 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Ballard Power Systems Inc (NASDAQ: BLDP) Has Great Upside Potential - Stocks Register

Nov 01, 2024
pulisher
Nov 01, 2024

Is Structure Therapeutics Inc ADR (NASDAQ: GPCR) A Good Investment For New Investors Now? - Stocks Register

Nov 01, 2024
pulisher
Oct 31, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

Biopharma Co. Can't Knock Ex-CFO's Bias Suit Out Of Court - Law360

Oct 30, 2024
pulisher
Oct 30, 2024

Armata Pharmaceuticals Announces Structural Biology Publication - StockTitan

Oct 30, 2024
pulisher
Oct 30, 2024

Some of the Major Key Players in the oral proteins and peptides market are - InsightAce Analytic

Oct 30, 2024
pulisher
Oct 28, 2024

Secretome Therapeutics, Inc. Announces Composition of Matter Patents for Lead Assets STM-01 and STM-21 - Business Wire

Oct 28, 2024
pulisher
Oct 26, 2024

Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $86.80 - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

GPCR drugmaker Septerna amasses $288M in IPO - BioPharma Dive

Oct 24, 2024
pulisher
Oct 17, 2024

Griffin Asset Management Inc. Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Structure Therapeutics Inc ADR (GPCR) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Exchange Traded Concepts LLC Has $1.80 Million Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Structure Therapeutics Inc ADR Inc. (GPCR) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

Daily Progress: Structure Therapeutics Inc ADR (GPCR) Drop -1.39, Closing at 38.32 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Is Structure Therapeutics Inc ADR (GPCR) a threat to investors? - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Down 2.7%Here's What Happened - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Structure Therapeutics Inc ADR: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Top investors say Structure Therapeutics Inc ADR (GPCR) ticks everything they need - SETE News

Oct 10, 2024
pulisher
Oct 10, 2024

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch. - BioPharma Dive

Oct 10, 2024
pulisher
Oct 10, 2024

Weight Loss Drugs Market Top Trends 2024-2031 - InsightAce Analytic

Oct 10, 2024
pulisher
Oct 09, 2024

Market Recap Check: Structure Therapeutics Inc ADR (GPCR)’s Positive Finish at 40.50, Up/Down 0.30 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect? - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Up 3.7%Here's What Happened - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

The Manufacturers Life Insurance Company Buys 32,839 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Structure Therapeutics Inc ADR (GPCR) is a good investment, but the stock may be overvalued - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

27,094 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Bank of Montreal Can - MarketBeat

Oct 07, 2024
pulisher
Oct 05, 2024

35,700 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Renaissance Technologies LLC - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

Marshall Wace LLP Raises Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

3 AI Stocks to Buy as Nvidia Sputters - InvestorPlace

Oct 04, 2024
pulisher
Oct 02, 2024

Are Structure Therapeutics Inc ADR (GPCR) shares a good deal now? - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% Higher - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

GentiBio Appoints Mark Bach, M.D., Ph.D., as Chief Medical Officer - BioSpace

Sep 30, 2024
pulisher
Sep 30, 2024

Nasdaq Global Select Market Composite Index (NQGS) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

S&P 100 Index (OEX) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

Ratios Uncovered: Breaking Down Structure Therapeutics Inc ADR (GPCR)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Makes New Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Acquires Shares of 34,852 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Structure Therapeutics' SWOT analysis: small-cap biotech's stock potential in obesity market - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

This Weight-Loss Stock Just Scored A New Street-High Price Target - Barchart

Sep 30, 2024
pulisher
Sep 29, 2024

18,803 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Purchased by Scientech Research LLC - MarketBeat

Sep 29, 2024
pulisher
Sep 29, 2024

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now? - Insider Monkey

Sep 29, 2024
pulisher
Sep 28, 2024

Driehaus Capital Management LLC Has $101.20 Million Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

Closing Figures Unveiled: Structure Therapeutics Inc ADR (GPCR) Drop -4.70, Closes at 41.95 - The Dwinnex

Sep 26, 2024
pulisher
Sep 26, 2024

183,785 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Ensign Peak Advisors Inc - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk? - Morningstar

Sep 26, 2024
pulisher
Sep 26, 2024

European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading - MSN

Sep 26, 2024
pulisher
Sep 25, 2024

Does Structure Therapeutics Inc ADR (GPCR) offer a good opportunity for investors? - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Cantor Fitzgerald Weighs in on Structure Therapeutics Inc.'s FY2024 Earnings (NASDAQ:GPCR) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

1,000 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Sandia Investment Management LP - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

First Light Asset Management LLC Buys 441,534 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Structure Therapeutics Inc ADR (GPCR)’s stock chart: A technical perspective - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

First Light Asset Management LLC Has $23.20 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Up 7.1% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

HighVista Strategies LLC Has $1.38 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Structure Therapeutics Inc ADR: Weathering Stock Market Storms with 2.40B Market Cap - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

HighVista Strategies LLC Buys 19,338 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

HighVista Strategies LLC Reduces Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Structure Therapeutics’ (GPCR) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World

Sep 23, 2024
$19.96
price up icon 5.11%
$75.75
price down icon 0.50%
$376.80
price up icon 0.74%
$53.54
price down icon 2.00%
$207.25
price up icon 1.49%
$108.97
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):